FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Liothyronine Sodium Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Mylan Pharmaceuticals Inc. (New 03/28/2018)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
Liothyronine Sodium 5mcg tablets (NDC 0378-3611-01) 03/28/2018 The discontinuation of this product is a business decision
Liothyronine Sodium 25mcg tablets (NDC 0378-3612-01) 03/28/2018 The discontinuation of this product is a business decision

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English